| ~(153)Sm-EDTMP治疗骨转移癌疼痛的现状 |
| |
| 引用本文： | 李惠平. ~(153)Sm-EDTMP治疗骨转移癌疼痛的现状[J]. 国际放射医学核医学杂志, 2000, 0(3) |
| |
| 作者姓名： | 李惠平 |
| |
| 作者单位： | 北京大学第三医院肿瘤化疗放射病科!北京100083 |
| |
| 摘 要： | 以往骨转移癌病人疼痛治疗的常用方法是放疗和阶梯性使用止痛药物。随着核医学的发展 ,亲骨性放射性核素越来越多地用于癌症的治疗 ,尤其是骨转移癌的止痛治疗。其中 ,1 5 3 Sm- EDTMP(1 5 3 Sm-乙二胺四甲撑膦酸 )在缓解疼痛 ,改善生活质量 ,减少新的骨转移病灶发生 ,及降低治疗费用等方面都有很大优势
|
| 关 键 词： | 骨转移癌 疼痛 ~(153)Sm-乙二胺四甲撑膦酸 |
Treatment status of painful bone metastases with ~(153)Sm-EDTMP |
| |
| LI Hui ping. Treatment status of painful bone metastases with ~(153)Sm-EDTMP[J]. International Journal of Radiation Medicine and Nuclear Medicine, 2000, 0(3) |
| |
| Authors: | LI Hui ping |
| |
| Abstract: | The typical management of painful bone metastases is radiation therapy and the graduated use of opiate analgesics. As the development of nuclear medicine,bone seeking radiopharmaceuticals have been utilized in cancer treatment,especially in management painful bone metastases. 153 Sm EDTMP (samarium 153 ethylenediaminetetramethylene phosphonate) offers a good choice of treating method in palliating pain, improving quality of life, decreasing the rate at which new painful sites develop, and decreasing management costs. |
| |
| Keywords: | bone metastases pain 153 Sm ethylenediaminetetramethylene phosphonat |
| 本文献已被 CNKI 等数据库收录！ |
